A Study of LX107 Gene Therapy in AIPL1-IRD Patients

NCT07063030 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Retinal Dystrophy

Interventions

GENETIC: LX107 Injection

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]